Novel breast tissue feature strongly associated with risk of breast cancer

Journal of Clinical Oncology

Volumn 27, Issue 35, 2009, Pages 5893-5898

  McKian, Kevin P ^a   Reynolds, Carol A ^a   Visscher, Daniel W ^a   Nassar, Aziza ^a   Radisky, Derek C ^a   Vierkant, Robert A ^a   Degnim, Amy C ^a   Boughey, Judy C ^a   Ghosh, Karthik ^a   Anderson, Stephanie S ^a   Minot, Douglas ^a   Caudill, Jill L ^a   Vachon, Celine M ^a   Frost, Marlene H ^a   Pankratz, V Shane ^a   Hartmann, Lynn C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEASUREMENT; PRIORITY JOURNAL; AGE; BIOPSY; BREAST; BREAST TUMOR; CASE CONTROL STUDY; CELL PROLIFERATION; GENETIC PREDISPOSITION; GENETICS; HYPERPLASIA; MIDDLE AGED; PARITY; PATHOLOGY; PEDIGREE; PRECANCER; PREDICTION AND FORECASTING; PREGNANCY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME;

ADULT; AGE FACTORS; BIOPSY; BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL PROLIFERATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERPLASIA; LOGISTIC MODELS; MIDDLE AGED; PARITY; PEDIGREE; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PREGNANCY; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 73349120291     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2008.21.5079     Document Type: Article

References (29)

1. Freedman AN, Seminara D, Gail MH, et al: Cancer risk prediction models: A workshop on development, evaluation, and application. J Natl Cancer Inst 97:715-723, 2005
2. Elmore JG, Fletcher SW: The risk of cancer risk prediction: "What is my risk of getting breast cancer?" J Natl Cancer Inst 98:1673-1675, 2006
3. Pankratz VS, Hartmann LC, Degnim AC, et al: Assessment of the accuracy of the Gail model in women with atypical hyperplasia. J Clin Oncol 26: 5374-5379, 2008
4. Hartmann LC, Sellers TA, Frost MH, et al: Benign breast disease and the risk of breast cancer. N Engl J Med 353:229-237, 2005
5. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146-151, 1985
6. Santen RJ, Mansel R: Benign breast disorders. N Engl J Med 353:275-285, 2005
7. Wellings SR, Jensen HM, Marcum RG: An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 55:231-273, 1975
8. Geschickter CF: Diseases of the Breast (ed 2). Philadelphia, PA, J.B. Lippincott, 1945
9. Vorrherr H: The Breast: Morphology, Physiology, and Lactation. New York, NY, Academic Press, 1974
10. Hutson SW, Cowen PN, Bird CC: Morphometric studies of age related changes in normal human breast and their significance for evolution of mammary cancer. J Clin Pathol 38:281-287, 1985
11. Milanese TR, Hartmann LC, Sellers TA, et al: Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98:1600-1607, 2006
12. Gail MN, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
13. Costantino JP, Gail MH, Pee D, et al: Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 91:1541-1548, 1999
14. Bondy ML, Newman LA: Assessing breast cancer risk: Evolution of the Gail Model. J Natl Cancer Inst 98:1172-1173, 2006
15. Rockhill B, Spiegelman D, Byrne C, et al: Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93:358-366, 2001
16. Shattuck-Eidens D, Oliphant A, McClure M, et al: BRCA1 sequence analysis in women at high risk for susceptibility mutations: Risk factor analysis and implications for genetic testing. JAMA 278:1242-1250, 1997
17. Frank TS, Deffenbaugh AM, Reid JE, et al: Clinical characteristics of individuals with germline mutations in BRCA1 and BRC2: Analysis of 10,000 individuals. J Clin Oncol 20:1480-1490, 2002
18. Parmigiani G, Berry D, Aguilar O: Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62: 145-158, 1998
19. Berry DA, Iversen ES Jr, Gudbjartsson DF, et al: BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20:2701-2712, 2002
20. Antoniou AC, Pharoah PPD, Smith P, et al: The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 91:1580-1590, 2004
21. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction. Cancer 73:643-651, 1994
22. Couch FJ, DeShano ML, Blackwood MA, et al: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415, 1997
23. Henson DE, Tarone RE, Nsouli H: Lobular involution: The physiological prevention of breast cancer. J Natl Cancer Inst 98:1589-1590, 2006
24. Bargmann W (ed): Handbuch der Mikroskopischen Anatomie des Menschen: Volume 3, Part 3, Haut und Sinnesorgane. Berlin, Germany, Springer-Verlag, 1957, pp 277-485
25. Kerlikowske K, Smith-Bindman R, Ljung B-M, et al: Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med 139:274-284, 2003
26. Cui Y, Page DL, Chlebowski RT, et al: Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women's Health Initiative. Cancer Causes Control 18:431-438, 2007
27. Maxwell AJ, Pearson JM, Bishop HM: Crude open biopsy rates for benign screen detected lesions no longer reflect breast screening quality: Time to change the standard. J Med Screen 9:83-85, 2002
28. Herrinton LJ, Barlow WE, Yu O, et al: Efficacy of prophylactic mastectomy in women with unilateral breast cancer: A Cancer Research Network Project. J Clin Oncol 23:4275-4286, 2005
29. Vierkant RA, Hartmann LC, Pankratz VS, et al: Lobular involution: Localized phenomenon or field effect? Breast Cancer Res Treat [epub ahead of print on July 1, 2008]